The recent surge in investments into niche pharmaceutical companies, particularly those focusing on groundbreaking therapies and complex drug development programs, has fueled what some are calling "High Roller Pharma." https://zoyagnud953827.blazingblog.com/40195558/high-investor-pharma-the-hazardous-wager